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Abstract
Background: Necrotizing enterocolitis (NEC) is a leading cause of death in preterm infants. Neonates weighing
<1500 grams are at the highest risk for acquiring NEC, with a prevalence of nearly 7-10%, mortality up to 30%, and
several long-term complications among survivors. Despite advancements in neonatal medicine, this disease remains
a challenge to treat. The aim of this study is to investigate the effect of NEC on gut epithelial tight junctions and its
barrier function using a NEC mouse model.
Methods: Three-day old C57BL/6 mouse pups were fed with Esbilac formula every 3 hours and then subjected to
hypoxia twice daily followed by cold stress. Dam fed pups from the same litters served as controls. Pups were
observed and sacrificed 96 hours after the treatments and intestines were removed for experiments. The successful
induction of NEC was confirmed by histopathology. Changes in tight junction proteins in NEC intestines were
studied by western blotting and immunofluorescent microscopy using specific protein markers. The gut leakage in
NEC was visualized using biotin tracer molecules.
Results: Our study results demonstrate that we induced NEC in >50% of experimental pups, pups lost nearly 40%
of weight and their intestines showed gross changes and microscopic changes associated with NEC. There were
inflammatory changes with loss of tight junction barrier function and disruption of tight junction claudin proteins
in the intestines of NEC mouse model. We have demonstrated for the first time that NEC intestines develop
increased leakiness as visualized by biotin tracer leakage.
Conclusions: NEC leads to breakdown of epithelial barrier due to changes in tight junction proteins with increased
leakiness which may explain the transmigration of microbes and microbial products from the gut lumen into the
blood stream leading to sepsis like signs clinically witnessed.
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Background
Necrotizing enterocolitis (NEC) is a common condition
seen in premature neonates born with birth weight
<1500g and leads to high morbidity, mortality and
long-term complications. The incidence of NEC as re-
ported in the literature varies between 7 to 10% with a
high mortality of up to 30% [1]. Survivors of this condi-
tion suffer from neurodevelopmental delays [2], poor
growth, and cholestasis due short bowel syndrome and
may require gut transplantation in rare cases [3].
The cardinal traits considered in the pathogenesis of
NEC include prematurity, microbial colonization, gen-
etic predisposition, intestinal immaturity, role of intes-
tinal barriers and response to inflammation by the
premature intestine. There is a direct correlation be-
tween gestational age and incidence of NEC with high-
est incidence seen in the most premature neonates [4].
Premature neonates have poorly organized and imma-
ture intestinal absorption, digestion and motility pat-
terns [5–9]. Intestinal microbial colonization in these
premature neonates is a critical factor and has been
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demonstrated from early descriptions of this disease
from almost four decades ago by Santulli et al [10].
Several animal studies have demonstrated the role of
Toll-like receptor 4 (TLR4) in NEC. TLR4 is known to
gradually increase in expression in the intestine until
term gestation at which point its expression is actively
down regulated. It has been reported that TLR4 senses
lipopolysaccharides and activation of TLR4 results in
local inflammation leading to destruction of the epithe-
lial barrier [11, 12].
Tight junction (TJ) proteins bind the epithelial and
endothelial cells together and form a barrier between the
intestinal lumen and blood stream [13]. They regulate pas-
sage of ions, water and small molecules through the para-
cellular pathway and thereby maintain distinct body
compartments and cellular function [13]. They were first
identified in 1986 [14]. Three distinct proteins were iden-
tified, Occludin [15], Claudins [16] and junctional adhe-
sion molecules (JAM) [17]. Since then, in addition to
discovery of newer TJ proteins, various animal models
have helped understand their presence in different organs
such as brain, intestines, etc. and demonstrated their crit-
ical functions depending on their location in the tissues.
Fujita et al. demonstrated the differential expression and
localization of various claudins in the intestine of a mouse
model [18]. There has been progressively better under-
standing of the role of TJ proteins in various diseases and
the genes [19, 20] encoding for these TJ proteins.
Intestinal permeability is tightly regulated by several
TJ proteins, especially the claudins. Claudins are a family
of TJ integral membrane proteins with at least 24 mem-
bers [21]. Claudin proteins are small molecules with ~22
kDa in molecular weight and express different isoforms
depending on the tissue and cell type [22]. Claudins
show a tissue-specific distribution pattern and are
expressed on epithelial linings of the GI tract [18].
It is known that preterm infants have higher intestinal
permeability than older children and adults because of
various mechanical and nonmechanical factors including
TJs that maintain the connections between adjacent
cells. The integrity of gut epithelial barrier is absolutely
essential for health of GI tract and any disease process
which leads to increased permeability to toxins, foreign
proteins or translocation of gut bacteria into the circula-
tion starts the process which eventually leads to NEC
[23]. Thus, maintenance of gut epithelial barriers by
claudins and other barrier function proteins remains
central in prevention of NEC. Claudins are known to
form pores which are size and charge-selective for vari-
ous molecules and their normal expression is critical for
preservation of epithelial lining. Claudins play a key role
in maintaining the epithelial barrier and protecting new-
borns from development of NEC. The aim of this study
is to examine the integrity of the TJs and its barrier
function in a NEC mouse model. The gut leakage in
NEC intestines was visualized for the first time by biotin
tracer molecules, demonstrating the loss of epithelial
barrier function in NEC intestines.
Methods
Neonatal NEC mouse model
Our animal use protocol was reviewed and approved by
the Animal Care and Use Committee of East Carolina
University (AUP#A182). All animals were housed in the
facility maintained by East Carolina University, which
provides in-house veterinary care. The animals were
kept in rooms at 22°C with a 12-h light-dark cycle. We
performed the animal experiments according to the
guidelines of East Carolina University and the National
Institute of Health on animal care and use. These guide-
lines are very similar to ARRIVE guidelines practiced by
investigators in the European Union [24]. Every effort
was made to minimize the pain and discomfort to the
animals during the experiments.
The 3-day old C57BL/6 pups were divided into 2
groups: dam fed control group (n=13) and experimental
group (n=13). The latter group was fed with 30-50 μl
33% Esbilac formula (Pet-Ag, New Hampshire, IL) every
3 hours for 96 hours using a 1.9 Fr feeding tube, sub-
jected to hypoxia (100% N2 for 60 seconds) and cold
stress (4°C for 10 min) twice a day for four days. Pups
were nursed in an incubator (37°C) during the 4-day
period and provided high calorie formula. Both the ex-
perimental and dam fed control pups were euthanized at
96 hours after start of the experiment. The gastrointes-
tinal tract was carefully dissected and visually evaluated
for signs of NEC (areas of bowel necrosis, intestinal
hemorrhage). NEC was confirmed by histopathology
using published tissue injury guidelines in mice [25, 26].
Intestinal samples were collected for histopathological
and immunofluorescent studies.
Histology examinations
Intestinal tissues isolated from control and NEC pups
were fixed in 10% formalin solution. After washed with
phosphate buffered saline (PBS), the fixed tissues were
processed through graded ethanol solutions. The 5 μm
tissue sections were cut using a cryostat. Hematoxylin &
Eosin (H&E) staining was performed according to the
published methods [27].
Western blot analysis
Intestinal tissues from control and NEC pups were
minced on ice, homogenized in RIPA buffer (1% Triton
X-100, 0.5% sodium deoxycholate, 0.2% SDS, 150 mM
NaCl, 10 mM Hepes, pH7.3, 2 mM EDTA, 10 μg/ml
each of chymostatin, leupeptin and pepstatin A) by pass-
ing 10 times through a 22-gauge needle, and centrifuged
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at 15,000 g for 30 minutes at 4°C to obtain tissue lysates.
The total protein concentration of each sample was mea-
sured using the BCA protein assay kit (Pierce, Rockford,
IL, USA) and adjusted to equal concentration (2 mg/ml).
Proteins in the SDS sample buffer were separated by
SDS-PAGE and transferred to nitrocellulose membranes.
After blocking by 5% nonfat dry milk, the membranes
were incubated with primary and secondary antibodies, re-
spectively. The signals were detected by enhanced chemi-
luminescence (Amersham, Arlington Heights, IL, USA).
Immunofluorescence microscopy
Intestinal tissues isolated from control and NEC pups
were frozen in liquid nitrogen. The 5 μm frozen sections
were cut using a cryostat. The frozen sections were fixed
in 100% acetone and blocked with 5% BSA. The primary
and secondary antibodies were applied to the intestinal
tissues, respectively. The immunofluorescent signals
were analyzed using a Zeiss Axio Imager M2 microscope
(Carl Zeiss, Thornwood, NY).
Tight junction permeability assay in vivo
This TJ in vivo permeability assay using biotin has been
published previously [28]. Biotins are small water-soluble
molecules. They are membrane impermeable reagents and
allow efficient labeling of proteins and primary amine -
containing macromolecules on the cell surface. Biotin re-
agents will not diffuse through the intercellular space if TJ
is intact. However, if TJ structure is disrupted, the biotin
molecule will penetrate into the intercellular space.
To examine the TJ barrier function, the pups were
anesthetized by intraperitoneal injection with 0.05ml/
10g body weight of Ketamine (18mg/ml) and Xylazine
(2mg/ml) at the end of NEC experiments. After ensuring
the pup was in deep anesthesia with paw pinch, the ab-
dominal cavity was opened by a surgical scissor. The
Sulfo-NHS-Biotin (MW: 556.59) diluted in 1 mg/mL
PBS was injected into the lumen of control and NEC
small intestines using a low-pressure syringe pump
(Harvard Apparatus). The injection was conducted at a
rate of 50 μl/min through a 25G needle connected to a
polyethylene tubing. Ten minutes after biotin injection,
intestines were dissected and embedded in O.C.T.
compound, then processed for immunofluorescence
light microscopy [28]. Biotin was detected by Texas
red-conjugated streptavidin.
After the tissue collection, pups were euthanized
by decapitation while under anesthesia. All these
procedures were approved by the East Carolina Uni-
versity (ECU) Animal Care and Use Committee and
conducted in compliance with guidelines from the
National Institute of Health and ECU on laboratory
animal care and use.
Statistical analysis
Statistical analysis was performed using either Origin8
(OriginLab, MA) or SIGMAPLOT (Systat Software, Inc.
CA) softwares. The differences between two groups were
analyzed using the unpaired Student’s t-test. The p-value
of < 0.05 will be considered significant.
Results
Gross and histological examinations of intestines
After 4 days of treatments, about 50% of thirteen-treated
pups developed NEC compared to none in the dam fed
group. The NEC pups were smaller in size and had an
average of 42% reduction of the weight compared to the
control pups at the end of the treatment (Fig. 1a). The
NEC intestines showed the clinical sign of the disease and
were inflamed and swollen in appearance (Fig. 1b). Grossly
necrotic bowel was seen mainly in the small intestines,
and part of the large intestine was also involved (Fig. 1c).
On microscopic examination, NEC intestines showed the
clear evidence of bloody necrotic changes as indicated by
the arrows when compared to the controls (Fig. 1c). The
NEC phenotype was confirmed by histopathology exami-
nations using a standard histopathological grading estab-
lished to diagnose NEC [26]. Control intestines showed
the intact villus structure and submucosa (Fig. 2a) while
NEC intestines had a disrupted villous mucosal structure.
Some NEC villi displayed complete sloughing of epithelial
cells with breach of epithelium barrier (Fig. 2b and c).
Altered expression and localization of TJ proteins and
elevation of inflammation marker proteins in NEC intestines
Western blot analysis showed an altered expression of
TJ claudin proteins. There was an increased expression
level of claudin-2 and decreased expression levels of
claudin-3, -4, and -7 in NEC intestines compared to
those of controls (Fig. 3a). In addition, the expression
levels of PARP, a protein that can induce a programmed
cell death, as well as inflammatory marker proteins
NF-kB and TGF-β were all up-regulated in the NEC in-
testines compared to the control intestines (Fig. 3b).
Immunofluorescent microscopy results indicated re-
duced immunostaining signals for claudin-3, -4, and -7
as indicated by arrows in NEC intestines (Fig. 4, arrows,
NEC) compared to those of control intestines (Fig. 4,
arrows, CON). In addition, the aggregated signals of
claudin-3, -4, and -7 could be clearly observed in NEC
intestinal tissues (Fig. 4, arrowheads in NEC).
Disruption of TJ barrier function in NEC intestines
To study whether NEC intestines have a leaky TJ or not,
biotin in vivo detection assay was employed. The biotin
staining signal was examined under the immunofluores-
cent light microscope. We found that NEC intestines dis-
played a diffusion of biotin signal through the intercellular
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space (Fig. 5, arrows in NEC). On the other hand, the
control intestines showed no sign of leakage of TJ
barrier. The biotin molecules were kept at the intes-
tinal surface facing the lumen where biotin was ap-
plied (Fig. 5, arrowhead, CON). The strong biotin
staining signal marked by asterisk reflected the
accumulation of biotin molecules into the intestinal
tissue (Fig. 5, asterisk in NEC).
Discussion
The conundrum of NEC will continue to be an important
challenge both for the practicing clinician and the basic
Fig. 2 H& E staining of control and NEC intestines. a: Tissue sections from representative control intestines shows the normal villous structure
with intact crypt region (arrows). b and c: Tissue sections from representative NEC intestinal samples. The induction of NEC led to stunting of villi
and disrupted villous structure with sloughing of epithelial cells into the lumen (L). The hemorrhage is evident in both B and C NEC intestinal
samples. Original magnification: 200×
Fig. 1 Establishment of necrotizing enterocolitis (NEC) mouse model. a: Weight measurement of dam-fed (CON) or NEC-treated (NEC) pups. The
treatment started at day 3 and was continued for 4 days. The data represent means ± s.e.m. from three independent experiments. Student’s t-test
was used for statistical analysis. A P value of < 0.05 was considered significant (*). N=10 pups for each group. b: Comparison of control and NEC
intestines in situ at the end of the experiments. The NEC intestine showed the swollen and discolored appearance. c: The control and NEC
intestines after removal from the body. The NEC intestine displayed the severe hemorrhage as indicated by arrows
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Fig. 3 Protein expression levels of control and NEC intestines. a: Representative western blot membrane showing claudin-2, -3, -4 and -7
expression levels in control (CON) and NEC intestines. Intestinal tissues from 7-day control and NEC pups were collected at the end of
experiments. Tissue lysates were solubilized in RIPA buffer and subjected to western blotting. b: PARP, NF-κB and TGF-β expression levels in
control (CON) and NEC intestines. A total of 30 μg protein for each sample were loaded on the SDS-polyacrylamide gel. Membranes were blotted
against specific antibodies. Actin served as a loading control. Three independent experiments were performed
Fig. 4 Immuno-localization of claudin proteins in control and NEC intestines. Representative images of intestines from 7-day control and NEC
pups were dissected from the body and frozen in liquid nitrogen. Frozen sections were immunostained with anti-claudin-3, or -4, or -7 antibodies
and detected by Cy3-conjugated secondary antibody. Nuclei were stained with DAPI (blue). The claudin signals were localized at cell-cell contact
area as indicated by arrows in controls (CON). Arrows were pointed to the reduced signals in NEC samples and arrowheads in NEC showed the
aggregated staining pattern. Scale bar: 50 μm
Ravisankar et al. BMC Pediatrics          (2018) 18:372 Page 5 of 8
science scientists. Though numerous studies have contrib-
uted to various aspects of pathogenesis of NEC, the funda-
mental etiopathogenesis remains a big unanswered
question. This study focused on the role of TJ integral
membrane protein claudins which play an essential role in
cellular integrity and barrier function in the intestine.
The integrity of TJs is vital in maintaining intestinal epi-
thelial homeostasis both at physiological condition and in
disease state. Our NEC mouse model indicates an altered
expression in the claudins where there is an increase in
expression of claudin-2 and with a decreased expression
of claudin-3, -4 and -7. It is well known that claudin-2
creates cation selective pores and increases cation perme-
ability in epithelia of various tissues including intestines
[29–31]. We observed an increased expression of
claudin-2 in our NEC intestines which is consistent with
the hypothesis of leaky TJs in NEC. The function of
claudin-3 and -4 in the intestine is well established as a
barrier and its down-regulation observed in our NEC
mouse model explains the loss of barrier function [32]. It
has been reported that claudin-7 is involved in cell-matrix
interactions [33, 34]. Reduced expression of claudin-7
could contribute to the loss of tissue integrity. Claudins
have been studied in human subjects and increased gut
permeability has been demonstrated in cases with NEC
[35, 36]. Thus, our study provides the molecular basis
behind the observed clinical effect. Further research could
focus on modulating TJ protein expression in the preterm
neonatal gut to prevent NEC.
Biotins are membrane impermeable reagents and there-
fore, will not diffuse through the intercellular space if TJ is
intact. However, if TJ structure/function is disrupted, the
biotin molecule will penetrate into the intercellular space.
Biotin permeability assay has been successfully applied to
many different in vivo systems to examine the TJ perme-
ability barrier, such as the blood brain barrier in
claudin-5-deficient mice [37], the blood brain barrier in
adult zebrafish [38], and the pathogen-infected intestinal
epithelia [39]. Our study also demonstrates the increased
gut permeability in NEC intestines. Disruption of TJ bar-
rier function in NEC intestines is visualized for the first
time by biotin in vivo detection assay. Disruption of epi-
thelial barrier has been studied in human infants using in-
direct markers of epithelial cells like fatty acid binding
protein (I-FABP). We did not use this marker in our
mouse model since intestinal injury was grossly visible in
affected animals.
Leaky TJs in NEC induce inflammation in the gut as
reported by other studies [11, 40–43]. Our current study
also observed increased signals for inflammatory
markers, NF-kB and TGF-β. Both NF-kB and TGF-β are
involved in the regulation of inflammatory processes. In
Fig. 5 Biotin permeability assays in control and NEC intestines. a: Sulfo-NHS-LC-Biotin was injected into the intestinal lumen of 7-day old control
(CON) or NEC pups. The tissue sections were stained with Texas red-conjugated streptavidin. Biotin was mainly kept at the epithelial surface of
control intestines (arrowhead) due to the intact epithelial barriers. No barrier leakage was observed in control intestines. In contrast, the leakage
was clearly detected in NEC intestines. Biotin stained the intercellular space (arrow) and connective tissue (Asterisk). V: Villus. b: The higher
magnification of the images. L: Lumen. Scale bar: 50 μm in A and 20 μm in B
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addition, it is worth pointing out that NEC induction
not only induces inflammatory response in GI tract, but
also in kidneys as we have previously reported [44]. Fur-
ther studies are necessary to better understand the rela-
tionship of a disrupted TJ structure/function with
inflammation and severity of the NEC and whether al-
tered expression of TJ protein claudins can be used as a
potential biomarker for NEC.
The major limitation of our current study is that it is
an animal study conducted using mice subjected to feed-
ing a hyperosmolar formula and periods of hypoxia
which is not exactly the same pathology seen in human
neonates where infection starts the NEC process in most
cases. But, at the same time inflammation which is the
end result, was witnessed in our mouse model as well.
Thus, there are similarities between clinical NEC and
what we witnessed in our mouse model. Our report sug-
gests that by modulating the expression of certain TJ
proteins and control of the inflammatory process could
potentially change the course of NEC. However, this goal
will require further basic and clinical research.
Conclusions
We have successfully induced NEC in a mouse model
where there was widespread inflammation and histological
changes like those seen in human neonates. Inflammation
was associated with increased expression of NF-κB,
TGF-β and PARP. There was increased expression of
Claudin-2 along with down-regulation of Claudins-3, -4,
and -7 which explains the reason for breakdown of the epi-
thelial barrier. We have demonstrated increased leakiness
through the epithelial lining using biotin tracer, that ex-
plains the clinical sepsis like features witnessed in neo-
nates. Thus, our report provides the molecular basis
behind the clinical picture of NEC and identifies mole-
cules where future therapies could be targeted.
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